The FORMAMP project focuses on innovative nanoformulation design of antimicrobial and immunomodulatory peptides in order to increase their efficiency and stability.
The FORMAMP consortium involves industrial partners providing antimicrobial peptide (AMP) drug candidates, novel nanomaterials for formulation as well as experience in drug delivery system development and production. The development and investigation of different nanostructured materials is performed with highly ranked European research groups. In addition, clinicians with experience in infectious diseases such as tuberculosis, cystic fibrosis and skin and soft tissue infections provide their valuable clinical opinion on therapeutic treatments. Efficiency of the novel formulations is assessed continuously in vitro and in vivo. Awareness of regulatory aspects is covered by the Medical Products Agency. The FORMAMP concept will make significant progress in the area of nanomedicine and treatment of infectious diseases.